In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents.
作者信息
Cedillo-Rivera R, Tapia-Contreras A, Torres J, Muñoz O
机构信息
Unidad de Investigación Médica en Enfermedades Infecciosas y Parasitarias, Hospital de Pediatria, Centro Médico Nacional Siglo XXI, IMSS, México, D.F., Mexico.
出版信息
Arch Med Res. 1997;28 Spec No:295-7.
PMID:9033107
Abstract
摘要
相似文献
1
In vitro susceptibility of Entamoeba histolytica to fluoroquinolones, nitrofurans and other antiamebic agents.
Arch Med Res. 1997;28 Spec No:295-7.
2
[Microscopy of the antiamebic activity of new nitroimidazoles].
Arch Invest Med (Mex). 1974;5 SUPPL 2:403-10.
3
Experimental amoebiasis and the development of anti-amoebic compounds.实验性阿米巴病与抗阿米巴化合物的研发
Parasitology. 1983 Feb;86 (Pt 1):175-91. doi: 10.1017/s0031182000057279.
4
5
Achievements and obstacles in research for new anti-amoebic drugs.
Arch Invest Med (Mex). 1978;9 Suppl 1:381-6.
6
7
[Study in vitro of the pharmacological action of antiamebic drugs].[抗阿米巴药物药理作用的体外研究]
Arch Invest Med (Mex). 1973:Suppl 1:87-92.
8
Further studies on the in vitro activity of gossypol as antiamebic agent.关于棉酚作为抗阿米巴药物的体外活性的进一步研究。
Arch Med Res. 1992;23(2):69-70.
9
Antiamoebic activity of drugs given singly and in combination against axenically grown Entamoeba histolytica.单独及联合使用药物对无菌培养的溶组织内阿米巴的抗阿米巴活性。
Arch Invest Med (Mex). 1978;9 Suppl 1:387-92.
10
In vitro activity of certain quassinoid anti-tumor agents against Entamoeba histolytica.某些苦木素类抗肿瘤药物对溶组织内阿米巴的体外活性。
Arch Invest Med (Mex). 1982;13 Suppl 3:43-9.
引用本文的文献
1
Hsp90 inhibitors as new leads to target parasitic diarrheal diseases.热休克蛋白90抑制剂作为治疗寄生性腹泻疾病的新先导药物。
Antimicrob Agents Chemother. 2014 Jul;58(7):4138-44. doi: 10.1128/AAC.02576-14. Epub 2014 May 12.
Zotero 插件